The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

"The decision between a bioprosthetic and a mechanical valve is one of the most consequential for patients requiring aortic ...

Researchers at the Thoracic Surgery research group, the Department of Molecular Medicine and Surgery, have performed a study of patients who underwent bioprosthetic aortic valve replacement in ...

The procedure that delivers a bioprosthetic device through flexible tube to a patient’s failing aortic valve didn’t originally have a name when it debuted more than 20 yours ago. Now—to the chagrin of ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary ...

This is the first randomized clinical trial of transcatheter aortic valve implantation (TAVI). It showed that 1-year outcomes are dramatically improved among patients who are not candidates for ...

CALC is the principal failure mode of BHV fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. Covalent binding of APD to residual glutaraldehyde in pericardial ...

Patients randomized to TAVR in this study received the Medtronic Evolut R, PRO or CoreValve bioprosthesis as new generation valves became available during the study. Aortic stenosis—when the ...

This is because space is required to accommodate the excluded native aortic valve leaflets, which otherwise could compromise coronary arterial flow. Since the Medtronic CoreValve device is a much ...

Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly ...